Cardiology Letters 2020, 29(2):93-96
CLARIFY registry - five-years follow-up of patients with chronic coronary syndrome
- I. interná klinika LFUK a UNB, Nemocnica Staré Mesto, Bratislava, Slovenská republika
Coronary artery disease (CAD) is one of the most common and serious cardiovascular (CV) diseases in the developed countries. Last year there was a change in the classification of CAD presented at the ESC Congress, 2019. The dynamic nature of the CAD process results in various clinical presentations, which can be categorized as either acute coronary syndromes (ACS) or chronic coronary syndromes (CCS). Stable CAD has been renamed to Chronic Coronary Syndrome (CCS). CLARIFY registry (32 703 patients with CCS from 45 countries) was a prospective observational registry (starting Nov 2009 - Jun 2010 with 5-years follow-up) and its data were analyzed: a) Primary outcome endpoint (CV mortality/nonfatal myocardial infarction, MI) rate was 8.0% (male: 8.1% and female: 7.6%), b) Cox proportional hazards model showed main independent predictors of primary end-point: prior hospitalization for heart failure, current smoking, atrial fibrillation, prior MI and stroke, diabetes, current angina and peripheral artery disease. c) There was an interaction between angina and prior MI. Among patients with prior MI was angina associated with higher primary event rate (11.8%) versus (8.2%) in patients without angina. Among patients without prior MI were event rates similar for patients with (6.3%) or without (6.4%) angina. Prescription rates of evidence based secondary prevention therapies were high. Patients with both angina and MI are in a high-risk subgroup and these patients need intensive treatment.
Keywords: chronic coronary syndrome; myocardial infarction; angina pectoris; cardiovascular mortality
Published: February 1, 2020 Show citation
References
- Timmis A, Townsend N, Gale C, et al. ESC Scientific Document Group. European Society of Cardiology: cardiovascular Disease Statistic 2017; Eur Heart J 2018;39:508-579.
Go to original source... - Puymirat E, Simon T, Cayla G, et al. Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI Program (French Registry of Acute ST-Elevation Myocardial Infarction) 1995 to 2015. Circulation 2017;136:1908-1919.
Go to original source... - Jernberg T, Johanson P, Held C, et al. SWEDEHEART/RIKS-HIA. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA 2011;305:1677-1684.
Go to original source... - Kannel WB, Feinleib M. Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol 1072;29:154-163.
Go to original source... - Emond M, Mock MB, Davis KB, et al. Long-term survival of medicaily treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation 1994;90:2645-2657.
Go to original source... - Daily CA, De Stavola B, Sendon JL, et al. Euro Heart Survey Investigators. Predicting prognosis in stable angina - results from the Euro heart survey of stable angina: prospective observational study. BMJ 2006;332:262-267.
Go to original source... - Sorbets E, Greenlaw N, Ferrari R, et al. Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease. Clin Cardiol 2017;40:797-806.
Go to original source... - Steg PK, Greenlaw N, Tendera M, et al. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the Interntional Observational CLARIFY Registry. JAMA Intern Med 2014;174:1651-1659.
Go to original source... - Murín J, Kamenský G. Register CLARIFY - pohľad na slovenské údaje po piatich rokoch. Cardiol Lett 2017;26:236-246.
- Murín J, Kamenský G. Register CLARIFY: pohľad na podskupinu chorých so stabilnou angínou pektoris. Cardiol Lett 2019,28:168-173.
- Sorbets E, Fox KM, Elber Y, et al. Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. Eur Heart J 2020;41:347-355.
Go to original source... - Cataparo AL, Graham I, De Backer, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2016;37:2999-3058.
Go to original source... - Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHAHA/ACC/ AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA// PCNA Guidelines on the management of blood cholesterol. Circulation 2019;139:e1082-e114.
Go to original source... - 2019 ESC Guidelines for the diagnosis and managment of chronic coronary syndroms. Eur Heart J 2019;00:1-71.

